VanEck Genomic Health Innovators ETF (CURE)
Market Closed
15 Oct, 03:30 PM
€
25. 50
+0.39
+1.5329%
€
- Market Cap
- Div Yield
6,783 Volume
€ 25.11
Previous Close Want to track CURE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
CURE closed yesterday higher at €25.5, an increase of 1.5329% from Wednesday's close, completing a monthly increase of 0.7905% or €0.2. Over the past 12 months, CURE stock gained 32.6053%.
CURE is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on XDUS (EUR).
CURE Chart
VanEck Genomic Health Innovators ETF (CURE) FAQ
What is the stock price today?
The current price is €25.50.
On which exchange is it traded?
VanEck Genomic Health Innovators ETF is listed on XETRA.
What is its stock symbol?
The ticker symbol is CURE.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has VanEck Genomic Health Innovators ETF ever had a stock split?
No, there has never been a stock split.
VanEck Genomic Health Innovators ETF Profile
| XETRA Exchange | US Country |
Contact Information
Address: -
Phone: -
2026 © Marketlog. All Rights Reserved.
